Literature DB >> 1506061

Serovar, biotype, phage type, toxigenicity & antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta.

T Ramamurthy1, A Pal, M K Bhattacharya, S K Bhattacharya, A S Chowdhury, Y Takeda, T Takeda, S C Pal, G B Nair.   

Abstract

Characteristics of V. cholerae isolated from patients of acute secretory diarrhoea admitted to the Infectious Diseases Hospital, Calcutta during two consecutive cholera seasons (1989 and 1990), with special emphasis on biotyping and toxigenicity, were investigated. The isolation rates of V. cholerae during 1989 and 1990 were 78 and 85.1 per cent respectively, with Inaba serotype dominating in 1989 and Ogawa in 1990. All the V. cholerae 01 strains isolated in this study belonged to biotype Eltor with phage type 4 dominating (48.8%). Most of the strains of V. cholerae were resistant to 10 and 150 micrograms/ml of 0/129 vibriostatic agent. Similarly, majority of the V. cholerae strains were resistant to furazolidone (95.7%), cotrimoxazole (83%) and tetracycline (63.1%) and several resistance patterns were encountered. All the V. cholerae 01 strains examined produced cholera toxin (CT) in amounts ranging between greater than 70 pg/ml and greater than 2.5 ng/ml. In contrast, all but one of the non-01 strains isolated in this study did not produce CT. Further studies are required to elucidate the mechanism involved in the pathogenesis of non-01 V. cholerae mediated diarrhoea.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506061

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  8 in total

1.  Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993 to 1995) analysis.

Authors:  A K Mukhopadhyay; S Garg; R Mitra; A Basu; K Rajendran; D Dutta; S K Bhattacharya; T Shimada; T Takeda; Y Takeda; G B Nair
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

Review 2.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  New type of cholera.

Authors:  Y Jain; B Das; M K Bhan
Journal:  Indian J Pediatr       Date:  1993 Sep-Oct       Impact factor: 1.967

4.  Nontoxigenic Vibrio cholerae 01 serotype Inaba biotype El Tor associated with a cluster of cases of cholera in southern India.

Authors:  P K Saha; H Koley; A K Mukhopadhyay; S K Bhattacharya; G B Nair; B S Ramakrishnan; S Krishnan; T Takeda; Y Takeda
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

5.  Purification and characterization of an extracellular secretogenic non-membrane-damaging cytotoxin produced by clinical strains of Vibrio cholerae non-O1.

Authors:  P K Saha; H Koley; G B Nair
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

6.  Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba from the prevailing O1 Ogawa serotype strains in India.

Authors:  P Garg; R K Nandy; P Chaudhury; N R Chowdhury; K De; T Ramamurthy; S Yamasaki; S K Bhattacharya; Y Takeda; G B Nair
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  Biotype traits and antibiotic susceptibility of Vibrio cholerae serogroup O1 before, during and after the emergence of the O139 serogroup.

Authors:  A K Mukhopadhyay; S Garg; G B Nair; S Kar; R K Ghosh; S Pajni; A Ghosh; T Shimada; T Takeda; Y Takeda
Journal:  Epidemiol Infect       Date:  1995-12       Impact factor: 2.451

8.  Changing Susceptibility Pattern of Vibrio cholerae O1 Isolates to Commonly Used Antibiotics in the Largest Diarrheal Disease Hospital in Bangladesh during 2000-2018.

Authors:  Irin Parvin; K M Shahunja; Soroar Hossain Khan; Tahmina Alam; Lubaba Shahrin; Mst Mahmuda Ackhter; Monira Sarmin; Sampa Dash; Muhammad Waliur Rahman; Abu Sadat Mohammad Sayeem Bin Shahid; Abu Syed Golam Faruque; Tahmeed Ahmed; Mohammod Jobayer Chisti
Journal:  Am J Trop Med Hyg       Date:  2020-05-21       Impact factor: 2.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.